Top Biotechnology companies in Australia by EBT Margin

This ranking features the top 17 Biotechnology companies in Australia ranked by EBT Margin, averaging a EBT Margin of -11,244.86%, for January 15, 2025.
#
Name
EBT Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
57.47%
June 30, 2024 USD 7.32 6.16%

Australia

2
22.97%
June 30, 2024 USD 173.13 0.11%

Australia

3
7.57%
June 30, 2024 USD 2.01 -0.68%

Australia

4
5.27%
June 30, 2024 USD 2.14 0.82%

Australia

5
1.66%
June 30, 2024 USD 1.33 6.17%

Australia

6
0.62%
Dec. 31, 2023 USD 15.47 4.25%

Australia

7
-20.07%
June 30, 2024 USD 0.62 -2.68%

Australia

8
-141.49%
June 30, 2024 USD 2.00 1.52%

Australia

9
-252.36%
June 30, 2024 USD 0.74 -1.40%

Australia

10
-330.99%
June 30, 2024 USD 3.66 3.57%

Australia

11
-365.26%
June 30, 2024 USD 2.37 1.84%

Australia

12
-474.65%
June 30, 2024 USD 3.31 -4.06%

Australia

13
-1,111.87%
June 30, 2024 USD 1.93 -0.52%

Australia

14
-1,171.97%
June 30, 2024 USD 1.53 1.32%

Australia

15
-1,493.51%
June 30, 2024 USD 1.58 -2.06%

Australia

16
-1,680.35%
Dec. 31, 2023 USD 5.88 0.14%

Australia

17
-184,215.67%
June 30, 2024 USD 3.82 6.70%

Australia

Frequently Asked Questions
  • Which Biotechnology company in Australia has the highest EBT Margin ?

    The Biotechnology company in Australia with the highest EBT Margin is Clinuvel Pharmaceuticals Limited (ASX: CUV.AX) at 57.47%.

  • Which Biotechnology company in Australia has the lowest EBT Margin ?

    The Biotechnology company in Australia with the lowest EBT Margin is Opthea Limited (NasdaqGS: OPT) at -184,215.67%.